Fludeoxyglucose (18F)

25 trials 13 recruiting VVarious

Filter these 25 trials by condition, phase, country and more.

Open in Search →

25 Registered trials

13 Recruiting

9 Completed trials

17 Sponsors

14 Countries

Phase III

Phase II

Phase IV

Phase III: 7 Phase II/III: 1 Phase II: 12 Phase I/II: 1 Phase IV: 3 Phase I (FiH): 1

Oversight events:

1 temporary halt 1 urgent safety measure 1 unexpected event across 3 trials

View oversight register →

Indications tested

Neuroendocrine carcinoma metastatic 2 Neuroendocrine carcinoma 2 Langerhans' cell histiocytosis 1 Ovarian cancer 1 Aortic stenosis 1 Gastric cancer 1 Langerhans cell sarcoma 1 Follicular lymphoma 1 Rosai-Dorfman syndrome 1 Erdheim-Chester disease 1 Huntington's disease 1 Marginal zone lymphoma 1

Sponsors using this IMP

Aalborg University Hospital 3 Centre Hospitalier Universitaire De Nantes 3 Rigshospitalet 3 Amsterdam UMC Stichting 2 Odense University Hospital 2 Academisch Ziekenhuis Maastricht 1 AskBio France 1 Barcelonabeta Brain Research Center 1 Centre Hospitalier Regional Et Universitaire De Brest 1 F. Hoffmann-La Roche AG 1 Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer 1 Institut Jules Bordet 1

All trials — page 2

25 total

Exploratory study evaluating the relevance of [68Ga]Ga-PentixaFor for initial staging and detection of minimal residual disease in multiple … Ended

2022-500339-35-01 Phase II 1 country Centre Hospitalier Universitaire De Nantes

Showing 25–25 of 25 trials

← All drugs A–Z